Women less likely to screen for breast cancer over false-positive mammograms

False-Positive Mammograms Impact Women's Screening Behavior

A recent study conducted by researchers from the University of California-Davis has brought to light a significant issue in the field of breast cancer screening. The study reveals that false-positive mammograms, which are initial positive results that do not result in a cancer diagnosis, are likely to deter women from further screenings. Sep 3, 2024
Abortion at home via pills safe till 12 weeks of pregnancy: The Lancet

Home-Based Medical Abortions: A Safe Alternative?

A study conducted by Swedish researchers and published in The Lancet journal has highlighted the safety and efficacy of managing abortion at home using pills. The study, led by Johanna Rydelius from the Sahlgrenska Academy, University of Gothenburg, Sweden, analyzed the experiences of 435 women who took the first dose of misoprostol, a pill used in medical abortions, either at home or in the hospital. Aug 30, 2024
Ozempic and the uncomfortable truth

Weight Loss Drugs: A New Perspective on Metabolic Activity

The world of weight loss medications is being reevaluated following a study led by Professor Donal O'Shea of St. Vincent's University Hospital (SVUH) and the UCD School of Medicine. The research focused on the medication Ozempic, a drug that has been under public scrutiny for some time. The study's findings, published in the Journal of the Obesity Society, challenge the prevailing belief that weight loss medications like Ozempic, Wegovy, or Monjaro primarily work by promoting satiety and reducing food intake. Aug 23, 2024
Mpox

India Braces for Mpox: A New Global Health Threat

The deadly new strain of Mpox, often referred to as monkeypox, has been spreading rapidly across the African continent and beyond, posing a significant threat to global public health. The virus, which was previously confined to isolated regions, is now inching closer to India, with neighboring Pakistan already reporting initial cases. Aug 23, 2024